Lenovo Group (OTCMKTS:LNVGY – Get Free Report) and Amarillo Biosciences (OTCMKTS:AMAR – Get Free Report) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability.
Insider & Institutional Ownership
0.1% of Lenovo Group shares are owned by institutional investors. 34.4% of Amarillo Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Lenovo Group and Amarillo Biosciences”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lenovo Group | $83.08 billion | 0.60 | $1.91 billion | $1.03 | 77.44 |
| Amarillo Biosciences | $20,000.00 | 0.00 | -$1.45 million | N/A | N/A |
Lenovo Group has higher revenue and earnings than Amarillo Biosciences.
Analyst Ratings
This is a summary of current recommendations and price targets for Lenovo Group and Amarillo Biosciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lenovo Group | 0 | 1 | 0 | 1 | 3.00 |
| Amarillo Biosciences | 0 | 0 | 0 | 0 | 0.00 |
Given Amarillo Biosciences’ higher probable upside, analysts plainly believe Amarillo Biosciences is more favorable than Lenovo Group.
Profitability
This table compares Lenovo Group and Amarillo Biosciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Lenovo Group | 0.88% | 34.51% | 5.14% |
| Amarillo Biosciences | -41,453.98% | N/A | -574.29% |
Volatility & Risk
Lenovo Group has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Amarillo Biosciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500.
Summary
Lenovo Group beats Amarillo Biosciences on 9 of the 11 factors compared between the two stocks.
About Lenovo Group
Lenovo Group Limited, an investment holding company, develops, manufactures, and markets technology products and services. It operates through Intelligent Devices Group, Infrastructure Solutions Group, and Solutions and Services Group segments. The company offers commercial and consumer personal computers, as well as servers and workstations; and a family of mobile Internet devices, including tablets and smartphones. In addition, it provides laptops, monitors, accessories, smart home and collaboration solutions, augmented and virtual reality, commercial internet of things, and smart infrastructure data center solutions. Further, the company manufactures and distributes IT products, computers, computer hardware, and peripheral equipment; and offers IT, business planning, management, supply chain, finance, administration support, procurement agency, data management, intellectual property, and investment management services. Additionally, it is involved in the retail and service business for consumer electronic products and related digital services; development, ownership, licensing, and sale of communications hardware and software; and develops software and applications. Furthermore, the company distributes smartphone, tablet, server, and storage. It operates in China, the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Lenovo Group Limited was founded in 1984 and is headquartered in Quarry Bay, Hong Kong.
About Amarillo Biosciences
Amarillo Biosciences, Inc., a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases. The Medical division focuses on medical devices and developing technology to treat metabolism related diseases, such as Type 1 and Type 2 diabetes. The Consumer division provides a range of nutraceutical and food supplement products that utilize a liposomal delivery system. It owns four issued patents related to the low-dose oral delivery of interferon; one patent is for a product promoting oral health; and three patents are associated with treatment of metabolic disorders. The company was incorporated in 1984 and is based in Amarillo, Texas.
Receive News & Ratings for Lenovo Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lenovo Group and related companies with MarketBeat.com's FREE daily email newsletter.
